2009•Medical RecapitulateRequires access

Effect of Rosiglitazone on Cardiovascular System in Patients with Type 2 Diabetes

Chen Jian-jia

Abstract

Rosiglitazone can cure diabetes by activating peroxisome proliferator activated receptor(PPARγ) and then reducing the insulin resistance,increasing the sensitivity of peripheral tissue to issue,promoting function of beta cells,decreasing theblood sugar,improving the blood sugar,blood fat and blood pressure of type 2 diabetes,and reducing the genesis of cardiovascular diseases.This article reviewed the effect of rosiglitazone on cardiovascular diseases and related mechanisms in treating type 2 diabetes.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Rosiglitazone, Type 2 diabetes, Medicine, Insulin resistance, Blood sugar, Diabetes mellitus, Internal medicine, Endocrinology